ZNF268 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.008590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.050600E-01
Normal-vs-Stage2
5.548100E-02
Normal-vs-Stage3
3.966100E-02
Normal-vs-Stage4
9.763400E-01
Stage1-vs-Stage2
5.444100E-02
Stage1-vs-Stage3
3.506200E-02
Stage1-vs-Stage4
7.122600E-01
Stage2-vs-Stage3
1.858180E-01
Stage2-vs-Stage4
3.268300E-02
Stage3-vs-Stage4
3.926100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.094790E-01
Normal-vs-AfricanAmerican
3.529200E-01
Normal-vs-Asian
2.288000E-02
Caucasian-vs-AfricanAmerican
7.875800E-01
Caucasian-vs-Asian
6.285800E-02
AfricanAmerican-vs-Asian
1.812420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.270190E-01
Normal-vs-Female
8.422100E-02
Male-vs-Female
8.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.160000E-01
Normal-vs-Age(41-60Yrs)
1.670600E-01
Normal-vs-Age(61-80Yrs)
7.574100E-02
Normal-vs-Age(81-100Yrs)
1.797600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.150000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.531560E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.711800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.049500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.535200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.553500E-02
Normal-vs-Daily Drinker
1.884350E-02
Normal-vs-Weekly Drinker
4.268200E-02
Normal-vs-Occasional Drinker
1.893420E-01
Normal-vs-Social Drinker
3.808600E-01
Non Drinker-vs-Daily Drinker
4.716400E-01
Non Drinker-vs-Weekly Drinker
6.969000E-01
Non Drinker-vs-Occasional Drinker
1.668560E-01
Non Drinker-vs-Social Drinker
1.119590E-01
Daily Drinker-vs-Weekly Drinker
8.269600E-01
Daily Drinker-vs-Occasional Drinker
5.694500E-02
Daily Drinker-vs-Social Drinker
4.785800E-02
Weekly Drinker-vs-Occasional Drinker
1.430790E-01
Weekly Drinker-vs-Social Drinker
1.244010E-01
Occasional Drinker-vs-Social Drinker
7.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.341010E-01
Normal-vs-Grade 2
2.109600E-02
Normal-vs-Grade 3
3.754300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.115200E-01
Grade 1-vs-Grade 3
7.796200E-01
Grade 1-vs-Grade 4
1.341010E-01
Grade 2-vs-Grade 3
1.511160E-01
Grade 2-vs-Grade 4
2.109600E-02
Grade 3-vs-Grade 4
3.754300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.308400E-02
Normal-vs-NonDiabetic
7.475500E-02
Diabetic-vs-NonDiabetic
9.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.139500E-03
Normal-vs-NoPancreatitis
9.431600E-02
Pancreatitis-vs-NoPancreatitis
6.172400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.914180E-01
Normal-vs-N1
6.678300E-02
N0-vs-N1
9.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.599800E-01
Normal-vs-TP53-NonMutant
4.880200E-01
TP53-Mutant-vs-TP53-NonMutant
9.197600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
